Cencora Inc (COR)
235.48
+1.59
(+0.68%)
USD |
NYSE |
Nov 05, 11:30
Cencora Enterprise Value: 47.40B for Nov. 4, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
November 04, 2024 | 47.40B |
November 01, 2024 | 47.48B |
October 31, 2024 | 46.27B |
October 30, 2024 | 46.54B |
October 29, 2024 | 46.99B |
October 28, 2024 | 47.34B |
October 25, 2024 | 47.52B |
October 24, 2024 | 47.65B |
October 23, 2024 | 47.53B |
October 22, 2024 | 47.46B |
October 21, 2024 | 47.92B |
October 18, 2024 | 48.10B |
October 17, 2024 | 47.75B |
October 16, 2024 | 47.93B |
October 15, 2024 | 47.25B |
October 14, 2024 | 45.62B |
October 11, 2024 | 45.18B |
October 10, 2024 | 45.11B |
October 09, 2024 | 44.91B |
October 08, 2024 | 44.84B |
October 07, 2024 | 44.58B |
October 04, 2024 | 44.67B |
October 03, 2024 | 44.87B |
October 02, 2024 | 45.00B |
October 01, 2024 | 45.51B |
Date | Value |
---|---|
September 30, 2024 | 45.68B |
September 27, 2024 | 45.65B |
September 26, 2024 | 45.44B |
September 25, 2024 | 45.35B |
September 24, 2024 | 45.73B |
September 23, 2024 | 46.31B |
September 20, 2024 | 46.27B |
September 19, 2024 | 45.97B |
September 18, 2024 | 46.34B |
September 17, 2024 | 47.53B |
September 16, 2024 | 48.84B |
September 13, 2024 | 48.58B |
September 12, 2024 | 48.14B |
September 11, 2024 | 47.86B |
September 10, 2024 | 48.12B |
September 09, 2024 | 47.92B |
September 06, 2024 | 47.62B |
September 05, 2024 | 47.86B |
September 04, 2024 | 49.27B |
September 03, 2024 | 49.33B |
August 30, 2024 | 48.52B |
August 29, 2024 | 48.13B |
August 28, 2024 | 47.91B |
August 27, 2024 | 47.33B |
August 26, 2024 | 47.51B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
16.27B
Minimum
Mar 23 2020
52.33B
Maximum
Apr 03 2024
32.70B
Average
33.46B
Median
Feb 18 2022
Enterprise Value Benchmarks
Cardinal Health Inc | 29.38B |
McKesson Corp | 71.91B |
Weed Inc | 5.088M |
Pineapple Inc | -- |
Zomedica Corp | 40.25M |
Enterprise Value Related Metrics
Net Income (Quarterly) | 483.46M |
Revenue (Quarterly) | 74.24B |
Total Expenses (Quarterly) | 73.49B |
EPS Diluted (Quarterly) | 2.42 |
Gross Profit Margin (Quarterly) | 3.25% |
Profit Margin (Quarterly) | 0.65% |
Earnings Yield | 3.91% |
Operating Earnings Yield | 6.35% |
Normalized Earnings Yield | 4.800 |